These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 33665052)
1. An Urban Center Experience Exploring Barriers to Adherence to Endoscopic Surveillance for Non-Dysplastic Barrett's Esophagus. Isseh M; Mueller L; Abunafeesa H; Imam Z; Shakaroun D; Abu Ghanimeh M; Isseh N; Miller J; Jafri SM; Lenhart A Cureus; 2021 Jan; 13(1):e13030. PubMed ID: 33665052 [TBL] [Abstract][Full Text] [Related]
6. Impact of advanced endoscopic imaging on Barrett's esophagus in daily clinical practice. Beg S; Mensa M; Fullard M; Finerty E; Richman P; Leahy A Gastrointest Endosc; 2018 May; 87(5):1189-1194. PubMed ID: 28958906 [TBL] [Abstract][Full Text] [Related]
7. High definition versus standard definition white light endoscopy for detecting dysplasia in patients with Barrett's esophagus. Sami SS; Subramanian V; Butt WM; Bejkar G; Coleman J; Mannath J; Ragunath K Dis Esophagus; 2015; 28(8):742-9. PubMed ID: 25209721 [TBL] [Abstract][Full Text] [Related]
8. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Wani S; Rubenstein JH; Vieth M; Bergman J Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561 [TBL] [Abstract][Full Text] [Related]
10. Frequency of endoscopic surveillance for Barrett's esophagus is influenced by health insurance status: results from a population-based analysis. Faqih A; Broman KK; Huang LC; Phillips SE; Holzman MD; Pierce RA; Poulose BK; Yachimski PS Dis Esophagus; 2017 Nov; 30(11):1-8. PubMed ID: 28881902 [TBL] [Abstract][Full Text] [Related]
11. Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus. van der Wel MJ; Klaver E; Duits LC; Pouw RE; Seldenrijk CA; Offerhaus G; Visser M; Ten Kate F; Biermann K; Brosens L; Doukas M; Huysentruyt C; Karrenbeld A; Kats-Ugurlu G; van der Laan JS; van Lijnschoten G; Moll F; Ooms A; Tijssen JG; Bergman J; Meijer SL United European Gastroenterol J; 2019 Aug; 7(7):889-896. PubMed ID: 31428413 [TBL] [Abstract][Full Text] [Related]
12. Over-Utilization of Repeat Upper Endoscopy in Patients with Non-dysplastic Barrett's Esophagus: A Quality Registry Study. Wani S; Williams JL; Komanduri S; Muthusamy VR; Shaheen NJ Am J Gastroenterol; 2019 Aug; 114(8):1256-1264. PubMed ID: 30865017 [TBL] [Abstract][Full Text] [Related]
13. Endoscopy in Barrett's esophagus. Surveillance during reflux management and new advances in the diagnosis and early detection of dysplasia. el Khoury J; Sahai AV Chest Surg Clin N Am; 2002 Feb; 12(1):47-58. PubMed ID: 11901932 [TBL] [Abstract][Full Text] [Related]
14. A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts. Hoefnagel SJM; Mostafavi N; Timmer MR; Lau CT; Meijer SL; Wang KK; Krishnadath KK PLoS One; 2020; 15(4):e0231419. PubMed ID: 32282835 [TBL] [Abstract][Full Text] [Related]
15. Predictors of dysplastic and neoplastic progression of Barrett’s esophagus. Alnasser S; Agnihotram R; Martel M; Mayrand S; Franco E; Ferri L Can J Surg; 2019 Apr; 62(2):93-99. PubMed ID: 30907564 [TBL] [Abstract][Full Text] [Related]
16. Optical detection and eradication of dysplastic Barrett's esophagus. Song LM; Wang KK Technol Cancer Res Treat; 2003 Aug; 2(4):289-302. PubMed ID: 12892511 [TBL] [Abstract][Full Text] [Related]
17. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204 [TBL] [Abstract][Full Text] [Related]
18. Screening and surveillance for complications related to gastroesophageal reflux disease. Spechler SJ Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938 [TBL] [Abstract][Full Text] [Related]
19. Characterization of tissue autofluorescence in Barrett's esophagus by confocal fluorescence microscopy. Kara MA; DaCosta RS; Streutker CJ; Marcon NE; Bergman JJ; Wilson BC Dis Esophagus; 2007; 20(2):141-50. PubMed ID: 17439598 [TBL] [Abstract][Full Text] [Related]
20. Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective? Inadomi JM; Saxena N Dig Dis Sci; 2018 Aug; 63(8):2094-2104. PubMed ID: 29948571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]